Association of capn10 snps and haplotypes with polycystic ovary syndrome among south indian women

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Dasgupta, Shilpi ^a   Sirisha, Pisapati V S ^a   Neelaveni, Kudugunti ^b   Anuradha, Katragadda ^c   Reddy, B Mohan ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

^b OSMANIA GENERAL HOSPITAL   (India)

^c Anu Test Tube Baby Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN 10; CALPAIN;

ADOLESCENT; ADULT; ARTICLE; CAPN10 GENE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; INDIAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; DNA SEQUENCE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PHENOTYPE; STATISTICAL MODEL; TEMPERATURE;

ADOLESCENT; ADULT; ALLELES; CALPAIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; MIDDLE AGED; MODELS, STATISTICAL; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; TEMPERATURE;

EID: 84857546333     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032192     Document Type: Article

References (23)

1. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J, (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22: 141-146.
2. Legro RS, Kunselman AR, Dodson WC, Dunaif A, (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84: 165-169.
3. Ehrmann DA, (2002) Glucose Intolerance in Polycystic Ovary Syndrome: Role of the Beta Cell. In: Chang RJ, Heindel JJ, Dunaif A, editors. Polycystic Ovary Syndrome New York Marcel Dekker Inc pp. 89-103.
4. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, et al. (1999) Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci 96: 8573-8578.
5. Villuendas G, Escobar-Morreale HF, Tosi F, Sancho J, Moghetti P, et al. (2003) Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome. Fertil Steril 79: 219-220.
6. El Mkadem SA, Lautier C, Macari F, Molinari N, Lefe'bvre P, et al. (2001) Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to severe insulin resistance of women with polycystic ovary syndrome. Diabetes 50: 2164-2168.
7. Ehrmann DA, Schwarz PE, Hara M, Tang X, Horikawa Y, et al. (2002) Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 87: 1669-1673.
8. Gonzalez A, Abril E, Roca A, Aragon MJ, Figueroa MJ, et al. (2002) CAPN10 alleles are associated with polycystic ovary syndrome. J Clin Endocrinol Metab 87: 3971-3976.
9. Gonzalez A, Abril E, Roca A, Aragon MJ, Figueroa MJ, et al. (2003) Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients. J Clin Endocrinol Metab 88: 5529-5536.
10. Escobar-Morreale HF, Peral B, Villuendas G, Calvo RM, Sancho J, et al. (2002) Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism. Fertil Steril 77: 581-587.
11. Haddad L, Evans JC, Gharani N, Robertson C, Rush K, et al. (2002) Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. J Clin Endocrinol Metab 87: 2606-2610.
12. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26: 163-175.
13. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, et al. (2001) Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 69: 544-552.
14. Weedon MN, Schwarz PE, Horikawa Y, Iwasaki N, Illig T, et al. (2003) Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am J Hum Genet 73: 1208-1212.
15. Vollmert C, Hahn S, Lamina C, Huth C, Kolz M, et al. (2007) Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians. Am J Physiol Endocrinol Metab 292: E836-E844.
16. Cassell PG, Jackson AE, North BV, Evans JC, Syndercombe-Court D, et al. (2002) Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes 51: 1622-1628.
17. Bodhini D, Radha V, Ghosh S, Sanapala KR, Majumder PP, et al. (2010) Association of calpain 10 gene polymorphisms with type 2 diabetes mellitus in Southern Indians. Metab Clin Exp 60: 681-688.
18. Adak S, Sengupta S, Chowdhury S, Bhattacharyya M, (2010) Co-existence of risk and protective haplotypes of Calpain 10 gene to type 2 diabetes in the eastern Indian population. Diab & Vasc Disease Res 7: 63-68.
19. Franks S, Gharani N, McCarthy M, (2001) Candidate genes in polycystic ovary syndrome. Hum Reprod Update 7: 405-410.
20. Sreenan SK, Zhou YP, Otani K, Hansen PA, Currie KPM, et al. (2001) Calpains play a role in insulin secretion and action. Diabetes 50: 2013-2020.
21. The Rotterdam ESHRE/ASRM-sponsored PCOS Concensus Workshop Group (2004) Revised 2003 Concensus on diagnostic criteria and long term health risk related to Polycystic Ovary Syndrome. Fertil Steril 81: 19-25.
22. Mifsud A, Ramirez S, Yong EL, (2000) Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. J Clin Endocrinol Metab 85: 3484-3488.
23. Sambrook J, Fritschi EF, Maniatis T, (1989) Molecular cloning: a laboratory manual New York Cold Spring Harbor Laboratory Press.